GSE212057 SIRT6 overexpression 5 v 0 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE212057_SIRT6 overexpression_5_v_0_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE212057_SIRT6 overexpression_5_v_0_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE212057_SIRT6 overexpression_5_v_0_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE212057_SIRT6 overexpression_5_v_0_human_up.

Results found

Linked to

 

Label

Description

 

Gene

tripartite motif containing 16 like (pseudogene)

Gene

ARPIN-AP3S2 readthrough

Gene

long intergenic non-protein coding RNA 511

Gene

BAIAP2 divergent transcript

Gene

p53 upregulated regulator of p53 levels

Gene

H3 clustered histone 6

Gene

NmrA like redox sensor 2, pseudogene

Gene

MT-ND2 pseudogene 28

Gene

IGFL2 antisense RNA 1

Gene

KRT7 antisense RNA 1

  • Gene

    tripartite motif containing 16 like (pseudogene)


  • Gene

    ARPIN-AP3S2 readthrough


  • Gene

    long intergenic non-protein coding RNA 511


  • Gene

    BAIAP2 divergent transcript


  • Gene

    p53 upregulated regulator of p53 levels


  • Gene

    H3 clustered histone 6


  • Gene

    NmrA like redox sensor 2, pseudogene


  • Gene

    MT-ND2 pseudogene 28


  • Gene

    IGFL2 antisense RNA 1


  • Gene

    KRT7 antisense RNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.